Elevated serum soluble neprilysin (sNEP) is associated with greater cardiomyocyte injury and more severe cardiac output decline in doxorubicin-induced cardiotoxicity.
Does doxorubicin alter neprilysin expression and do sNEP levels correlate with myocardial damage in a rat model of anthracycline-induced cardiotoxicity?
Chronic doxorubicin exposure reduces LV neprilysin protein expression, and elevated serum soluble neprilysin correlates with early cardiomyocyte injury and chronic decline in cardiac output, suggesting its potential as a biomarker for anthracycline-induced cardiotoxicity.
Absolute Event Rate: 0% vs 0%
Chronic DOX exposure reduces LV NEP protein expression. Elevated serum sNEP is associated with greater early cardiomyocyte injury, while in chronic AIC, it correlates with a more severe decline in cardiac output. These findings suggest sNEP may be a potential biomarker for AIC.
Sobiborowicz et al. (Thu,) reported a other. Elevated serum soluble neprilysin (sNEP) is associated with greater cardiomyocyte injury and more severe cardiac output decline in doxorubicin-induced cardiotoxicity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: